RxDoctor Payments Data

Arie Belldegrun

Urology · Los Angeles, CANPI 1013932847

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,779,968 of the $1,800,699 with a category attached, or 98.8%. Urogen Pharma, Inc. accounts for 100.0% of it on its own, with 2 other manufacturers making up the rest. Among urology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,800,699in general payments, 2019–2025

Across 68 payments — averaging $26,481 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Urogen Pharma, Inc.$1.8M
  • Rochester Medical Corporation$226
  • C. R. Bard, Inc. & Subsidiaries$26

What the payments were for

  • Speaking & faculty fees$1,779,96899%
  • Travel & lodging$18,6481%
  • Food & beverage$2,0830%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Urogen Pharma, Inc.45$1,800,446
Rochester Medical Corporation22$226
C. R. Bard, Inc. & Subsidiaries1$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,800,699 in reported general payments places this provider in the 95th percentile of 1,324 urology providers in California.

See all urology providers in California →

Other urology in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →